Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Psychiatrische Dienste Graubuenden
ClinicalTrials.gov Identifier:
NCT01769014
First received: January 14, 2013
Last updated: January 15, 2013
Last verified: January 2013
  Purpose

It is the goal of this study adherence and quality of life in a population of people suffering from schizophrenia or schizoaffective disorder and to analyze if these factors are influenced by treatment, support, social services, and residential treatment. The study population is drawn from the the cantons Glarus and Graubunden as well as Liechtenstein.


Condition
Schizophrenia
Schizoaffective Disorder
Quality of Life

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: In the Cantons Graubunden and Glarus as Well as in the Principality of Liechtenstein: Influence of Intensive Outpatient Treatment of People With Schizophrenia and Schizoaffective Disorder on Quality of Life and Adherence

Resource links provided by NLM:


Further study details as provided by Psychiatrische Dienste Graubuenden:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2013
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

People who suffer from schizophrenia or schizoaffective disorder, following DSM IV criteria and who live in the cantons Glarus, Graubuenden or the Principality of Liechtenstein.

Criteria

Inclusion Criteria:

  • Schizophrenia or schizoaffective disorder
  • 18 - 65 years old
  • treated in the PDGR within the past 19 years

Exclusion Criteria:

  • organic brain disorder
  • alcohol or drug dependence
  • low intelligence
  • unable to give consent
  • no legal competency
  • lacking knowledge of German language
  • current psychiatric inpatient treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01769014

Locations
Switzerland
Psychiatrische Dienste Graubuenden
St. Moritz, Graubuenden, Switzerland, 7500
Sponsors and Collaborators
Psychiatrische Dienste Graubuenden
  More Information

No publications provided

Responsible Party: Psychiatrische Dienste Graubuenden
ClinicalTrials.gov Identifier: NCT01769014     History of Changes
Other Study ID Numbers: KEK-ZH-Nr.2012-0178
Study First Received: January 14, 2013
Last Updated: January 15, 2013
Health Authority: Switzerland: Ethikkommission

Keywords provided by Psychiatrische Dienste Graubuenden:
adherence

Additional relevant MeSH terms:
Disease
Psychotic Disorders
Schizophrenia
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on October 29, 2014